dc.contributor.advisor | Aman, Adi Koesoema | |
dc.contributor.advisor | Lindarto, Dharma | |
dc.contributor.author | Handayani, Tut Wuri | |
dc.date.accessioned | 2021-07-30T02:53:29Z | |
dc.date.available | 2021-07-30T02:53:29Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | http://repositori.usu.ac.id/handle/123456789/38450 | |
dc.description.abstract | Background: Fibrinogen plays an important role in the process of
thrombosis both primary (platelets aggregation) and secondary (blood
coagulation), and also play a role in increasing blood viscosity thus spur
the process of the formation of the plaques ateromatous and thrombosis.
Aim : To see the differences in the fibrinogen levels on the subject of
metabolic syndrome and obesity.
Method: This cross-sectional study was carried out with observational
analytic approach, in Department of internal medicine division Endocrine
RSUP H. Adam Malik Medan, February-April 2013, in 15 subject with
metabolic syndrome and 15 subject with obesity
Results: In our study the mean level of fibrinogen on the SM group was
(542.9± 209.3) and obese group was (503.5 ± 192.8), but not significantly
different with (p=0.633). And also there was no correlation between
fibrinogen levels with metabolic syndrome components
Conclusion: There are increased of Fibrinogen levels in metabolic
syndrome group compared with obese group, although there was no
significantly difference. There is no correlation between the fibrinogen
levels and metabolic syndrome component. | en_US |
dc.description.abstract | Latar Belakang : Fibrinogen memegang peranan penting pada proses
thrombosis baik primer (agregasi thrombosit) maupun sekunder (koagulasi
darah), juga berperan dalam meningkatkan viskositas darah sehingga
memacu proses terbentuknya plak ateromatous dan selanjutnya
thrombosis.
Tujuan : Untuk melihat perbedaan kadar fibrinogen pada subjek sindroma
metabolik dan obesitas.
Metode : Studi cross sectional ini dilakukan dengan metode observational
analitik, di Poli Penyakit Dalam bagian Endokrin RSUP H Adam Malik
Medan, Februari - April 2013 pada 15 subjek sindroma metabolik dan 15
subjek obesitas.
Hasil : Pada penelitian kami nilai rata-rata fibrinogen pada kelompok SM
adalah 542.9± 209.3 mg/dl sedangkan pada kelompok obesitas
503.5±192.8 mg/dl dengan (p= 0.633), dan perbedaan ini tidak bermakna
secara statistik. Tidak terdapat korelasi antara kadar fibrinogen dengan
komponen sindrom metabolik
Simpulan : Terdapat peningkatan kadar Fibrinogen pada kelompok
sindroma metabolik dibandingkan dengan kelompok obesitas, walaupun
secara statistik tidak berbeda bermakna. Tidak terdapat korelasi antara
fibrinogen dengan komponen sindroma metabolik. | en_US |
dc.language.iso | id | en_US |
dc.publisher | Universitas Sumatera Utara | en_US |
dc.subject | Fibrinogen | en_US |
dc.subject | sindroma metabolik | en_US |
dc.subject | obesitas | en_US |
dc.title | Penilaian Kadar Fibrinogen pada Subjek Sindroma Metabolik dan Obesitas | en_US |
dc.identifier.nim | NIM097111004 | |
dc.description.pages | 98 Halaman | en_US |